Ftse Mib
33.830,41
0,28%
DAX
17.958,38
0,29%
S&P 500
5.064,20
0,91%
NASDAQ
15.840,96
1,51%
Bitcoin
59.340,70
0,37%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Relay Therapeutics Inc (RLAY) Relay Therapeutics Inc (RLAY) Notizie

Relay Therapeutics Inc

RLAY
7,08
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:09:40
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
02/5/202422:05GLOBERelay Therapeutics Reports First Quarter 2024 Financial..
25/4/202422:05GLOBERelay Therapeutics to Announce First Quarter 2024 Financial..
11/4/202422:05GLOBERelay Therapeutics to Participate in Upcoming Investor..
26/2/202422:05GLOBERelay Therapeutics to Participate in Three Upcoming Investor..
22/2/202422:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/2/202422:16EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202422:10EDGAR2Form 8-K - Current report
22/2/202422:05GLOBERelay Therapeutics Reports Fourth Quarter and Full Year 2023..
15/2/202422:05GLOBERelay Therapeutics to Announce Fourth Quarter and Full Year..
01/2/202422:05GLOBERelay Therapeutics to Participate in the Guggenheim..
31/1/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202415:22EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
10/1/202415:14EDGAR2Form D - Notice of Exempt Offering of Securities
08/1/202413:05EDGAR2Form 8-K - Current report
08/1/202413:00GLOBERelay Therapeutics Announces $30 Million Private Placement..
02/1/202422:05GLOBERelay Therapeutics to Present at 42nd Annual J.P. Morgan..
29/12/202322:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202322:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202322:16EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
07/11/202322:05GLOBERelay Therapeutics to Participate in Stifel 2023 Healthcare..
02/11/202321:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:10EDGAR2Form 8-K - Current report
02/11/202321:05GLOBERelay Therapeutics Reports Third Quarter 2023 Financial..
01/11/202321:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202321:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202322:05GLOBERelay Therapeutics to Announce Third Quarter 2023 Financial..
12/10/202322:13EDGAR2Form 8-K - Current report
12/10/202322:05GLOBERelay Therapeutics Announces Initial RLY-4008..
29/9/202323:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202322:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202322:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202322:05GLOBERelay Therapeutics to Present Clinical Data on RLY-4008 in..
08/8/202322:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:14EDGAR2Form 8-K - Current report
08/8/202322:02GLOBERelay Therapeutics Reports Second Quarter 2023 Financial..
01/8/202322:05GLOBERelay Therapeutics to Announce Second Quarter 2023 Financial..
31/7/202322:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/6/202323:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/6/202323:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/5/202323:01GLOBERelay Therapeutics Announces Full Dose Escalation Data for..
24/5/202322:05GLOBERelay Therapeutics to Participate in Two Upcoming Investor..
04/5/202322:05GLOBERelay Therapeutics Reports First Quarter 2023 Financial..
Apertura: Min: Max:
Chiusura: 7,08

La tua Cronologia

NASDAQ
RLAY
Relay Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network